Scynexis (SCYX) Cash from Operations (2013 - 2026)
Scynexis (SCYX) posted Cash from Operations of 8101000.0 for Q1 2026, down 144.02% on a QoQ basis from 18401000.0 in Q4 2025, and down 8.52% year-over-year from 8855464.2 in Q1 2025.
Scynexis (SCYX) Cash from Operations (2013 - 2026) Analysis & Trends
Scynexis' Cash from Operations history runs 14 years deep, the most recent figure standing at 8101000.0 for Q1 2026.
- Quarterly Cash from Operations fell 8.52% year-over-year to 8101000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5919000.0 (up 78.45% YoY) and the FY2025 annual result came in at 5283000.0, up 78.0% from the prior year.
- Cash from Operations was 8101000.0 for Q1 2026 at Scynexis, down from 18401000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 74398000.0 in Q2 2023 and bottomed at 22806000.0 in Q4 2022.
- A 5-year average of 3359823.53 and a median of 8101000.0 in 2026 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 2006.46% — and 2023, when it surged 500.4%.
- Scynexis' Cash from Operations stood at 22806000.0 in 2022, then soared by 66.08% to 7735000.0 in 2023, then dropped by 28.08% to 9907000.0 in 2024, then soared by 285.74% to 18401000.0 in 2025, then tumbled by 144.02% to 8101000.0 in 2026.
- Business Quant data shows SCYX's Cash from Operations at 8101000.0 in Q1 2026, 18401000.0 in Q4 2025, and 8724000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | -8.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.10 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Sep 30, 2024 | 765,000.00 |
| Sep 30, 2024 | 765,000.00 |
| Jun 30, 2024 | -10.86 Mn |
| Jun 30, 2024 | -10.86 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Dec 31, 2023 | -7.74 Mn |
| Dec 31, 2023 | -7.74 Mn |